187 related articles for article (PubMed ID: 11273796)
1. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma.
Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
Pulm Pharmacol Ther; 2001; 14(2):141-7. PubMed ID: 11273796
[TBL] [Abstract][Full Text] [Related]
2. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
[TBL] [Abstract][Full Text] [Related]
3. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatic patients.
Wilson AM; Duong M; Pratt B; Dolovich M; O'Byrne PM
Allergy; 2006 May; 61(5):537-42. PubMed ID: 16629781
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
6. Changes in sputum eosinophils predict loss of asthma control.
Jatakanon A; Lim S; Barnes PJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):64-72. PubMed ID: 10619799
[TBL] [Abstract][Full Text] [Related]
7. Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Neighbour H; Engelstätter R; Hellwig M; Kon OM; Barnes PJ; Hansel TT
Chest; 2008 Oct; 134(4):740-745. PubMed ID: 18403668
[TBL] [Abstract][Full Text] [Related]
8. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
[TBL] [Abstract][Full Text] [Related]
10. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma.
Jatakanon A; Kharitonov S; Lim S; Barnes PJ
Thorax; 1999 Feb; 54(2):108-14. PubMed ID: 10325913
[TBL] [Abstract][Full Text] [Related]
11. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A
Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345
[TBL] [Abstract][Full Text] [Related]
12. Ciclesonide improves measures of small airway involvement in asthma.
Cohen J; Douma WR; ten Hacken NH; Vonk JM; Oudkerk M; Postma DS
Eur Respir J; 2008 Jun; 31(6):1213-20. PubMed ID: 18287130
[TBL] [Abstract][Full Text] [Related]
13. Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation.
Prosperini G; Rajakulasingam K; Cacciola RR; Spicuzza L; Rorke S; Holgate ST; Di Maria GU; Polosa R
J Allergy Clin Immunol; 2002 Dec; 110(6):855-61. PubMed ID: 12464950
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
von Berg A; Engelstätter R; Minic P; Sréckovic M; Garcia Garcia ML; Latoś T; Vermeulen JH; Leichtl S; Hellbardt S; Bethke TD
Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: a double-blind, placebo-controlled study.
Adachi M; Ishihara K; Inoue H; Kudo K; Takahashi K; Morita Y; Masuda K; Takada Y; Kato R; Miyamoto T
Respirology; 2007 Jul; 12(4):566-72. PubMed ID: 17587424
[TBL] [Abstract][Full Text] [Related]
16. Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma.
Nakaji H; Petrova G; Matsumoto H; Iwata T; Ito I; Oguma T; Inoue H; Tajiri T; Nagasaki T; Kanemitsu Y; Niimi A; Mishima M
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):198-203.e3. PubMed ID: 23548532
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
Vermeulen JH; Gyurkovits K; Rauer H; Engelstätter R
Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
[TBL] [Abstract][Full Text] [Related]
19. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.
Kharitonov SA; Yates DH; Barnes PJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):454-7. PubMed ID: 8542158
[TBL] [Abstract][Full Text] [Related]
20. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
